Navigation Links
CardioDx to Present at the 12th Annual Needham Healthcare Conference

PALO ALTO, Calif., April 23, 2013 /PRNewswire/ -- CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that the company will present at the 12th Annual Needham Healthcare Conference on Tuesday, April 30, 2013 at 9:40 AM ET at the Westin Grand Central Hotel in New York. David Levison , the company's President and Chief Executive Officer, will provide an overview of CardioDx and Corus® CAD, the only clinically validated gene expression test for obstructive coronary artery disease (CAD).


CardioDx recently announced the publication of the COMPASS (Coronary Obstruction Detection by Molecular Personalized Gene Expression) study in Circulation: Cardiovascular Genetics, a journal of the American Heart Association. Results of the prospective, multi-center U.S. study showed that Corus CAD outperformed traditional stress testing with myocardial perfusion imaging (MPI), demonstrating high accuracy with both a higher sensitivity (89 percent vs. 27 percent) and higher negative predictive value (96 percent vs. 88 percent) than MPI for assessing the presence of obstructive CAD. 

With a simple blood draw, Corus CAD can safely, accurately and conveniently help primary care clinicians and cardiologists assess whether or not a stable non-diabetic patient's symptoms are due to obstructive CAD, enabling many patients to avoid unnecessary noninvasive and invasive cardiac procedures and exposure to imaging-related radiation risks or imaging agent intolerance. Corus CAD is the only sex-specific test for obstructive CAD, accounting for critical biological differences between men and women. Corus CAD has been used commercially by clinicians in more than 35,000 patients and is a covered benefit for more than 40 million Medicare enrollees in the U.S.

Corus CAD has been recognized by The Wall Street Journal's Technology Innovation Awards, honored as a Gold Edison Award recipient, and named one of TIME's Top Ten Medical Breakthroughs. CardioDx was recently honored as one of FierceMedicalDevices' "Fierce 15" most promising privately-held medical device and diagnostic companies.

About CardioDx

CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, is committed to developing clinically validated tests that empower clinicians to better tailor care to each individual patient. Strategically focused on coronary artery disease, cardiac arrhythmia and heart failure, CardioDx is poised to expand patient access and improve healthcare quality and efficiency through the commercialization of genomic technologies. For more information, please visit

Forward-Looking Statements

This press release may contain forward-looking statements, including statements regarding the efficacy and size of the market for Corus CAD. These statements relate to future events and involve known and unknown risks, uncertainties and other factors that could cause actual levels of activity, performance or achievement to differ materially from those expressed or implied by these forward-looking statements. These statements reflect the views of CardioDx as of the date of this press release with respect to future events and, except as required by law, it undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this press release.

SOURCE CardioDx, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CardioDx to Present at Cowen and Company 33rd Annual Healthcare Conference
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
4. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
5. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
6. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
8. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
9. Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
10. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
11. Anlit to Present New Dietary Supplements for Children at Vitafoods Europe 2012
Post Your Comments:
(Date:11/30/2015)... Belgium , Nov. 30, 2015   VolitionRx ... on developing blood-based diagnostic tests for a broad range of ... present at the LD Micro Conference, which will be held ... Attending from VolitionRx will be David Kratochvil ... , Vice President of Investor Relations. ® ...
(Date:11/30/2015)... Israel , Nov. 30, 2015 /PRNewswire/ ... on acquiring and developing innovative therapies for ear, nose, ... Keith A. Katkin as chairman of the ... , chief executive officer for OticPharma, Ltd.  "Keith brings ... chairman, he will be able to share this experience ...
(Date:11/29/2015)... 29, 2015   Royal Philips  (NYSE: PHG, AEX: ... at the 2015 Radiological Society of North America Annual ... Place in Chicago . Visitors to ... company,s broad portfolio of integrated Diagnostic Imaging, Clinical Informatics, ... clinical performance, improve workflow and create a superior patient ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... The American Society for Clinical ... of World AIDS Day 2015. On Nov. 30, ASCP shared its “Give a minute. ... World AIDS Day and the importance of getting tested for HIV. , ASCP has ...
(Date:11/30/2015)... ... November 30, 2015 , ... According to ... Ph.D., a senior scientist at Consumer Reports as supporting a “A Call for ... exposure limits. , The original Nov 2015 CR story titled, “Does Cell-Phone Radiation ...
(Date:11/30/2015)... ... November 30, 2015 , ... While powdered supplements and ... wasted time. Fortunately, an inventor from Chesterfield, Va., has found an easy to keep ... the scoop used to measure powdered contents in a canister or other container handy ...
(Date:11/30/2015)... Ill. (PRWEB) , ... November 30, 2015 , ... ... Decision Support Solutions, announced at the Radiology Society of North America (RSNA) annual ... have seen over 60% growth from 2014. Throughout 2015, the company has ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... its industry-leading suite of automated breast density assessment and enterprise analytics solutions, ... November 29-December 4, 2015 (South Hall booth #2377). Volpara’s quantitative breast imaging ...
Breaking Medicine News(10 mins):